Related Experiment Video

Updated: May 26, 2026

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

Emerging therapies for thyroid carcinoma

S Walsh1, R Prichard, A D K Hill

  • 1Department of Surgery, RCSI Smurfitt Building, Beaumont Hospital, Dublin 9, Ireland. siunw@yahoo.co.uk

The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
|January 12, 2012
PubMed

Insights

Thyroid cancer incidence is rising globally. This review covers new therapies for well-differentiated and medullary thyroid cancer, and future directions for anaplastic thyroid carcinoma treatment.

Area of Science:

  • Endocrinology and oncology, focusing on endocrine malignancies.

Background:

  • Thyroid carcinoma is the most common endocrine malignancy, with increasing global incidence.
  • Genetic mutations (e.g., BRAF, RET) drive thyroid cancer development, enabling targeted therapies.
  • Anaplastic thyroid carcinoma (ATC) remains a challenging subtype with a poor prognosis.

Purpose of the Study:

  • To review emerging novel therapies for well-differentiated and medullary thyroid carcinoma.
  • To discuss advances and future directions in managing anaplastic thyroid carcinoma.

Main Methods:

  • Literature review of recent advancements in thyroid cancer treatment.
  • Analysis of targeted therapies based on genetic mutations.
  • Exploration of novel therapeutic strategies and future research directions.

Main Results:

  • Targeted therapies show promise for specific thyroid cancer subtypes based on genetic profiles.
  • Emerging treatments offer new hope for well-differentiated and medullary thyroid carcinomas.
  • Significant challenges remain in improving outcomes for anaplastic thyroid carcinoma.

Conclusions:

  • Novel therapies are transforming the treatment landscape for differentiated and medullary thyroid cancers.
  • Continued research is crucial for developing effective treatments for anaplastic thyroid carcinoma.
  • Personalized medicine approaches, guided by genetic mutations, are key to advancing thyroid cancer care.

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach07:45

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach

Published on: November 28, 2025

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...